Teva Pharmaceutical Industries Ltd. - ערך בספרים למניה TEVA

Teva Pharmaceutical Industries (TEVA) dominates the generics sector due to its massive production volumes of components. By comparing the IFRS book value per share on GURU.Markets, we see that the value of 6.59 characterizes this level. Asset growth is supported by the robotization of packaging lines using AI and the conservative development of the portfolio through the release of complex biosimilars, which optimizes costs and strengthens capital.

For Teva Pharmaceutical Industries, the book value per share trend reflects the capitalization efficiency of this global generics leader's resources. The 6.59 metric is calculated as the ratio of equity minus intangible assets to the number of common shares. This metric demonstrates the real value of net assets available to an investor upon business liquidation. Steady growth in this value confirms the company's supply reliability and financial stability. This indicator serves as the foundation for assessing the business's intrinsic value.